[1] PETER BLANCKAERT. Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene[J]. Drug Testing and Analysis, 2019, 12 4: 422-430. DOI:
10.1002/dta.2738[2] MARJORIE S. MOOLTEN. Etonitazene: An opioid selective for the mu receptor types[J]. Life sciences, 1993, 52 18: Pages PL199-PL203. DOI:
10.1016/0024-3205(93)90118-m[3] MARTHE M. VANDEPUTTE. Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids.[J]. ACS Chemical Neuroscience, 2021. DOI:
10.22541/au.160520665.59016513/v2[4] ISTVáN UJVáRY*. DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles[J]. ACS Chemical Neuroscience, 2021, 12 7: 1072-1092. DOI:
10.1021/acschemneuro.1c00037[5] MENG-HUA M. TSAI, LEI SHI* In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling[J]. ACS Chemical Neuroscience, 2024, 15 4: 854-867. DOI:
10.1021/acschemneuro.3c00750[6] GRANT C GLATFELTER. Alkoxy chain length governs the potency of 2-benzylbenzimidazole “nitazene” opioids associated with human overdose.[J]. Psychopharmacology, 2023: 2573-2584. DOI:
10.1007/s00213-023-06451-2
